Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TeLuRide-008: EIK1001 plus pembrolizumab and chemotherapy for stage IV non-small cell lung cancer
CTR20263746Phase 3Active
- Sponsor
- Novotech
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of BDB001 in non-small cell lung cancer (NSCLC), sponsored by Novotech. Started Oct 2026; status: active.
02
Drugs
BDB001
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on CTR20263746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263746.